CFD-d on keerulised instrumendid, millega kaasneb võimenduse tõttu suur risk kiiresti raha kaotada. 84% jaeinvestoritest kaotab selle pakkuja juures CFD-dega kaubeldes raha. Mõelge järele, kas mõistate CFD-de toimimise põhimõtet ja kas saate endale lubada riski rahast ilma jääda.
US Eesti
Riik • United States
    Üksus • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    Ost-müük Aytu BioScience, Inc. - AYTU CFD

    1.568
    0%
    • Kokkuvõte
    • Ajaloolised andmed
    • Sündmused
    • Tuluaruanne
    • Bilanss
    • Rahavood
    • Omand
    Kauplemistingimused
    Hinnavahe 0.154
    Pika positsiooni ööpäeva tasu

    Long position overnight fee

    Margin. Your investment $1,000.00
    Üleöö tasu -0.025457 %
    Charges from borrowed part ($-1.02)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Mine platvormile
    		-0.025457%
    Lühikese positsiooni ööpäeva tasu

    Short position overnight fee

    Margin. Your investment $1,000.00
    Üleöö tasu 0.003235 %
    Charges from borrowed part ($0.13)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Mine platvormile
    		0.003235%
    Ööpäeva tasu aeg 21:00 (UTC)
    Min kauplemise kogus 0.01
    Valuuta USD
    Tagatis 20%
    Aktsiabörs United States of America
    Kauplemise vahendustasu 0%

    *Information provided by Capital.com

    Aytu Biopharma Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.

    Võtmestatistika
    Eelmine sulgemine* 1.568
    Avatud* 1.617
    Aastane muutus* 230%
    Päeva ulatus* 1.568 - 1.617
    52 nädala ulatus 1.40-16.19
    Keskmine maht (10 päeva) 49.71K
    Keskmine maht (3 kuud) 1.67M
    Turukapitalisatsioon 6.62M
    P/E suhtarv -100.00K
    Ringluses olevad aktsiad 3.78M
    Tulu 104.12M
    EPS -206.58
    Dividendid (% kasumist) N/A
    Beeta -0.37
    Järgmine tuluaruande kuupäev Sep 25, 2023

    Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Sulgemishind Change (%) Avamishind High Low
    Jun 6, 2023 1.568 -0.078 -4.74% 1.646 1.648 1.568
    Jun 5, 2023 1.687 -0.039 -2.26% 1.726 1.726 1.637
    Jun 2, 2023 1.736 0.139 8.70% 1.597 1.736 1.587
    Jun 1, 2023 1.647 0.060 3.78% 1.587 1.667 1.568
    May 31, 2023 1.618 -0.038 -2.29% 1.656 1.657 1.568
    May 30, 2023 1.618 -0.078 -4.60% 1.696 1.697 1.587
    May 26, 2023 1.627 0.000 0.00% 1.627 1.805 1.617
    May 25, 2023 1.618 -0.147 -8.33% 1.765 1.766 1.558
    May 24, 2023 1.746 -0.029 -1.63% 1.775 1.815 1.696
    May 23, 2023 1.765 -0.009 -0.51% 1.774 1.904 1.765
    May 22, 2023 1.874 0.020 1.08% 1.854 1.934 1.824
    May 19, 2023 1.844 0.020 1.10% 1.824 1.934 1.795
    May 18, 2023 1.835 0.020 1.10% 1.815 1.854 1.775
    May 17, 2023 1.736 0.090 5.47% 1.646 1.746 1.607
    May 16, 2023 1.677 0.001 0.06% 1.676 1.795 1.666
    May 15, 2023 1.726 0.011 0.64% 1.715 1.805 1.697
    May 12, 2023 1.776 -0.246 -12.17% 2.022 2.022 1.726
    May 11, 2023 2.022 -0.010 -0.49% 2.032 2.151 1.913
    May 10, 2023 2.002 0.060 3.09% 1.942 2.092 1.804
    May 9, 2023 1.953 0.326 20.04% 1.627 2.052 1.577

    Aytu BioScience, Inc. Events

    Kellaaeg (UTC) (UTC) Riik Sündmus
    Monday, September 25, 2023

    Kellaaeg (UTC) (UTC)

    20:00

    Riik

    US

    Sündmus

    Q4 2023 Aytu Biopharma Inc Earnings Release
    Q4 2023 Aytu Biopharma Inc Earnings Release

    Forecast

    -

    Previous

    -
    Monday, November 13, 2023

    Kellaaeg (UTC) (UTC)

    21:00

    Riik

    US

    Sündmus

    Q1 2024 Aytu Biopharma Inc Earnings Release
    Q1 2024 Aytu Biopharma Inc Earnings Release

    Forecast

    -

    Previous

    -
    Vaadake kõiki sündmusi
    • Aastas
    • Kvartalis
    2022 2021 2020 2019 2018
    Kogutulu 96.669 65.632 27.6321 7.32036 3.66012
    Tulu 96.669 65.632 27.6321 7.32036 3.66012
    Kulud, Kokku 44.386 36.432 7.55303 2.20204 2.05054
    Brutokasum 52.283 29.2 20.0791 5.11832 1.60958
    Kogu tegevuskulu 208.061 126.071 38.6481 33.9975 17.0825
    Müük/Üldine/admin kulud, kokku 69.88 55.808 34.8024 19.2396 17.7325
    Uuringud ja arendus 14.439 5.623 1.72142 0.58907 0.1676
    Depreciation / Amortization 4.067 6.009 4.49047 2.13626 1.55371
    Ootamatud kulutused (tulu) 75.289 22.199 -9.91925 9.83055 -4.42185
    Tulud majandustegevusest -111.392 -60.439 -11.016 -26.6772 -13.4224
    Intressitulud (kulu), muud tulud, neto -0.862 -2.05 -2.60466 -0.45472 3.2345
    Netotulu enne makse -110.283 -58.03 -13.6207 -27.1319 -10.1879
    Netotulu pärast makse -110.173 -58.289 -13.6207 -27.1319 -10.1879
    Netotulu enne erikulusid -110.173 -58.289 -13.6207 -27.1319 -10.1879
    Netotulu -110.173 -58.289 -13.6207 -27.1319 -10.1879
    Arvestatav tulu, v a erikulud -110.173 -58.289 -13.6207 -27.1319 -10.1879
    Arvestatav tulu, koos erikuludega -110.173 -58.289 -13.6207 -27.1319 -10.1879
    Jaotamisele kuuluv netotulu -110.173 -58.289 -13.6207 -27.1319 -10.1879
    Keskmine jaotamisele kuuluv aktsia kohta 0.07349 0.83733 0.22596 0.03897 0.00333
    Jaotatav EPS, v a erakorralised kulud -1499.08 -69.6126 -60.2791 -696.182 -3061.23
    Dividends per Share - Common Stock Primary Issue
    Jaotamisele kuuluv normaal-EPS -833.202 -52.3801 -104.177 -443.938 -4389.91
    Erakorralised kulud kokku 0
    Muud, neto 1.971 4.459
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Kogutulu 22.733 26.279 27.655 27.448 24.199
    Tulu 22.733 26.279 27.655 27.448 24.199
    Kulud, Kokku 9.99 8.986 9.623 12.606 11.513
    Brutokasum 12.743 17.293 18.032 14.842 12.686
    Kogu tegevuskulu 31.291 33.072 29.308 45.361 78.685
    Müük/Üldine/admin kulud, kokku 19.981 18.578 17.424 17.396 17.358
    Uuringud ja arendus 0.856 1.71 1.064 3.697 3.726
    Depreciation / Amortization 1.198 1.198 1.197 0.853 1.061
    Ootamatud kulutused (tulu) 0 2.6 10.809 45.027
    Tulud majandustegevusest -8.558 -6.793 -1.653 -17.913 -54.486
    Intressitulud (kulu), muud tulud, neto 1.358 0.1 1.08 -0.787 -0.055
    Muud, neto -0.128 0.999 1.468
    Netotulu enne makse -7.2 -6.693 -0.701 -17.701 -53.073
    Netotulu pärast makse -7.2 -6.693 -0.701 -17.701 -53.073
    Netotulu enne erikulusid -7.2 -6.693 -0.701 -17.701 -53.073
    Netotulu -7.2 -6.693 -0.701 -17.701 -53.073
    Arvestatav tulu, v a erikulud -7.2 -6.693 -0.701 -17.701 -53.073
    Arvestatav tulu, koos erikuludega -7.2 -6.693 -0.701 -17.701 -53.073
    Jaotamisele kuuluv netotulu -7.2 -6.693 -0.701 -17.701 -53.073
    Keskmine jaotamisele kuuluv aktsia kohta 3.72678 3.1103 0.1259 0.08989 1.48449
    Jaotatav EPS, v a erakorralised kulud -1.93196 -2.15188 -5.56812 -196.925 -35.7516
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Jaotamisele kuuluv normaal-EPS -1.93196 -1.31595 -5.56812 -76.6739 -5.42003
    Other Operating Expenses, Total -0.734
    • Aastas
    • Kvartalis
    2022 2021 2020 2019 2018
    Käibevarad kokku 59.929 105.234 75.4226 15.4329 9.47029
    Raha ja lühiajalised investeeringud 19.36 49.649 48.0817 11.0442 7.01253
    Raha ja ekvivalendid 19.36 49.649 48.0817 11.0442 7.01253
    Lühiajalised investeeringud
    Laekumata arved, neto 21.712 28.176 5.63272 1.74079 0.57878
    Accounts Receivable - Trade, Net 21.712 28.176 5.63272 1.74079 0.57878
    Total Inventory 10.849 16.339 9.99944 1.44007 1.33897
    Prepaid Expenses 7.375 9.78 5.71509 0.95778 0.44001
    Total Assets 137.623 265.668 153.293 34.7214 21.0601
    Property/Plant/Equipment, Total - Net 6.296 8.703 0.89261 0.20373 0.21868
    Goodwill, Net 0 65.802 28.0904 0
    Intangibles, Net 70.632 85.464 48.8546 19.0826 11.366
    Other Long Term Assets, Total 0.766 0.465 0.03298 0.0022 0.00509
    Total Current Liabilities 64.442 109.438 28.7634 5.37258 3.39478
    Payable/Accrued 9.468 8.689 0.959
    Accrued Expenses 35.946 49.485 11.1046 1.99724 0.72656
    Notes Payable/Short Term Debt 3.813 7.934 0 0 0
    Other Current Liabilities, Total 4.132 7.407 4.87523 1.07807 0.54855
    Total Liabilities 91.531 128.1 58.2778 27.6336 7.63559
    Total Long Term Debt 14.279 0.18 0 0 0
    Other Liabilities, Total 12.81 18.482 29.5145 22.261 4.24081
    Total Equity 46.092 137.568 95.0153 7.08782 13.4245
    Preferred Stock - Non Redeemable, Net 0 0 0 0.00036 0
    Common Stock 0.004 0.003 0.00126 0.00175 0.00018
    Additional Paid-In Capital 334.56 315.864 215.024 113.475 92.6819
    Retained Earnings (Accumulated Deficit) -288.472 -178.299 -120.01 -106.39 -79.2576
    Total Liabilities & Shareholders’ Equity 137.623 265.668 153.293 34.7214 21.0601
    Total Common Shares Outstanding 1.92894 1.37452 0.62919 0.08769 0.00897
    Other Current Assets, Total 0.633 1.29 5.9936 0.25 0.1
    Accounts Payable 10.987 19.255 11.8246 2.29727 2.11967
    Property/Plant/Equipment, Total - Gross 8.717 9.715 1.37661 0.59973 0.75868
    Accumulated Depreciation, Total -2.421 -1.012 -0.484 -0.396 -0.54
    Total Preferred Shares Outstanding 0 0 3.59498
    Current Port. of LT Debt/Capital Leases 0.096 16.668 0
    Capital Lease Obligations 0.084 0.18 0
    Long Term Debt 14.195
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Käibevarad kokku 78.465 70.611 74.415 59.929 77.947
    Raha ja lühiajalised investeeringud 19.179 19.501 23.811 19.36 27.613
    Raha ja ekvivalendid 19.179 19.501 23.811 19.36 27.613
    Laekumata arved, neto 34.043 25.547 27.924 21.712 27.613
    Accounts Receivable - Trade, Net 34.043 25.547 27.924 21.712 27.613
    Total Inventory 13.637 12.95 12.871 10.849 13.891
    Prepaid Expenses 10.429 11.989 9.024 7.375 7.942
    Other Current Assets, Total 1.177 0.624 0.785 0.633 0.888
    Total Assets 147.216 141.436 150 137.623 168.826
    Property/Plant/Equipment, Total - Net 4.395 5.019 5.648 6.296 7.04
    Property/Plant/Equipment, Total - Gross 7.779 8.083 8.384 8.717 8.78
    Accumulated Depreciation, Total -3.384 -3.064 -2.736 -2.421 -1.74
    Goodwill, Net 0 8.637
    Intangibles, Net 63.464 64.985 69.108 70.632 74.428
    Other Long Term Assets, Total 0.892 0.821 0.829 0.766 0.774
    Total Current Liabilities 85.416 67.15 73.204 64.442 80.36
    Accounts Payable 14.673 10.58 14.667 10.987 11.13
    Payable/Accrued 10.287 9.137 8.08 9.468 12.058
    Accrued Expenses 40.55 33.326 34.603 35.946 47.873
    Notes Payable/Short Term Debt 10.403 7.429 8.087 3.813 3.385
    Current Port. of LT Debt/Capital Leases 3.305 0.09 0.925 0.096 0.1
    Other Current Liabilities, Total 6.198 6.588 6.842 4.132 5.814
    Total Liabilities 106.304 95.619 96.094 91.531 107.682
    Total Long Term Debt 11.386 14.533 13.56 14.279 14.167
    Long Term Debt 11.371 14.494 13.498 14.195 14.061
    Capital Lease Obligations 0.015 0.039 0.062 0.084 0.106
    Other Liabilities, Total 9.502 13.936 9.33 12.81 13.155
    Total Equity 40.912 45.817 53.906 46.092 61.144
    Preferred Stock - Non Redeemable, Net 0 0 0 0 0
    Common Stock 0.00038 0.00034 0.006 0.004 0.003
    Additional Paid-In Capital 342.584 340.289 345.253 334.56 331.912
    Retained Earnings (Accumulated Deficit) -301.672 -294.472 -291.353 -288.472 -270.771
    Total Liabilities & Shareholders’ Equity 147.216 141.436 150 137.623 168.826
    Total Common Shares Outstanding 3.77951 3.38315 3.12147 1.92894 1.6678
    Total Preferred Shares Outstanding
    Other Equity, Total -0.00038 -0.00034
    • Aastas
    • Kvartalis
    2022 2021 2020 2019 2018
    Netotulu/algväärtus -110.173 -58.289 -13.6207 -27.1319 -10.1879
    Raha majandustegevusest -28.823 -25.964 -28.3739 -13.8314 -15.9403
    Raha majandustegevusest 10.251 9.201 6.24583 2.72707 2.59127
    Deferred Taxes
    Mittelikviidsed varad 81.962 21.443 -8.38913 10.7837 -7.62492
    Muutused tööjõus -10.863 1.681 -12.6099 -0.2102 -0.71881
    Tulu investeeringutelt -3.248 -2.782 -5.65577 -1.06199 -0.48429
    Kapitalikulutused -2.341 0 -0.05985 -0.07471
    Muud rahavood investeeringutelt, kokku -3.248 -0.441 -5.65577 -1.00214 -0.40959
    Rahavood investeeringutelt 1.53 30.314 71.0687 19.0751 22.6596
    Rahavoogudesse investeerimine -4.942 -10.996 -5.40415 -1.47996 -2.75752
    Aktsiate emiteerimine (tagasiost), neto 11.694 45.051 92.7217 15.555 25.4171
    Laenu väljastamine (kustutamine), neto -5.222 -3.741 -16.2488 5
    Rahaline kogumuutus -30.541 1.568 37.0391 4.1817 6.23499
    Makstud intressid 3.148 1.249 1.04028
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -14.594 -7.394 -2.881 -110.173 -92.472
    Cash From Operating Activities -14.494 -11.588 -9.148 -28.823 -21.728
    Cash From Operating Activities 6.699 4.505 2.328 10.251 8.005
    Non-Cash Items 1.658 3.846 1.488 81.962 67.39
    Cash Interest Paid 2.861 2.021 0.565 3.148 3.08
    Changes in Working Capital -8.257 -12.545 -10.083 -10.863 -4.651
    Cash From Investing Activities 0.038 0.037 0.042 -3.248 -3.207
    Other Investing Cash Flow Items, Total 0.038 0.037 0.042 -3.248 -3.207
    Cash From Financing Activities 14.275 11.692 13.557 1.53 2.647
    Financing Cash Flow Items -5.254 -3.497 -1.107 -4.942 -4.429
    Issuance (Retirement) of Stock, Net 13.012 11.573 10.416 11.694 12.7
    Issuance (Retirement) of Debt, Net 6.517 3.616 4.248 -5.222 -5.624
    Net Change in Cash -0.181 0.141 4.451 -30.541 -22.288
    Capital Expenditures
    Investori nimi Investori liik Ringluse protsent Hoitud osakud Muutus osakutes Hoidmise kuupäev Hinnang käibele
    Nantahala Capital Management, LLC Hedge Fund 7.1847 271595 0 2023-05-26 LOW
    Alyeska Investment Group, L.P. Hedge Fund 1.984 75000 0 2023-03-31
    Brooke (Christopher) Individual Investor 1.5438 58357 58357 2022-11-15
    Disbrow (Joshua R.) Individual Investor 1.5235 57591 -3 2023-03-24 LOW
    Renaissance Technologies LLC Hedge Fund 1.3127 49623 -57416 2023-03-31 HIGH
    Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 1.2503 47263 4379 2023-03-31 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 0.6365 24059 -1 2023-03-31 LOW
    Acadian Asset Management LLC Investment Advisor/Hedge Fund 0.5962 22537 2640 2023-03-31 MED
    Commonwealth Financial Network Investment Advisor 0.4137 15637 159 2023-03-31 LOW
    PGIM Quantitative Solutions LLC Investment Advisor 0.375 14176 5198 2023-03-31 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.3185 12039 -2 2023-03-31 LOW
    Oki (Mark K) Individual Investor 0.2513 9500 0 2023-03-24 LOW
    Pyszczymuka (Greg) Individual Investor 0.2408 9103 5000 2022-12-19
    Cantrell (Gary V.) Individual Investor 0.217 8204 -2000 2022-12-21
    Dockery (Carl C) Individual Investor 0.2157 8152 -2 2023-03-24 LOW
    Liu (Vivian H) Individual Investor 0.1805 6825 0 2023-03-24 HIGH
    Ronald Blue Trust, Inc. Investment Advisor 0.1476 5579 5300 2023-03-31 LOW
    UBS Financial Services, Inc. Investment Advisor 0.1395 5273 5012 2023-03-31 LOW
    Tower Research Capital LLC Hedge Fund 0.0457 1726 113 2023-03-31 HIGH
    Morgan Stanley & Co. LLC Research Firm 0.0228 861 0 2023-03-31 MED

    Miks valida Capital.com? Meie numbrid räägivad iseenda eest.

    Capital.com Group

    535K+

    Kauplejad

    87K+

    Igakuiste aktiivsete klientide arv

    $113M+

    Igakuine investeerimise maht

    $64M+

    Igakuiselt välja võetud

    Kauplemiskalkulaator

    Arvutage oma hüpoteetiline võit/kaotus, kui oleksite avanud CFD-tehingu ühel kindlal kuupäeval (valige kuupäev) ja sulgenud teisel kuupäeval (valige kuupäev).

    Kauplemise vahendustasu
    0
    • 1:1
    Finantsvõimendus
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investeering
    Tehingu suurus (võimendus x investeering):
    Avamishind

    Close

    Lühike Pikk
    Varasem tootlikkus ei ole tuleviku tulemuste hindamiseks usaldusväärne indikaator
    Kasum/Kaotus

    Aytu BioScience, Inc. Company profile

    Ettevõttest Aytu BioScience, Inc.

    Aytu Biopharma, Inc., varem Aytu BioScience, Inc., on spetsialiseeritud farmaatsiaettevõte. Ettevõte turustab retseptiravimite portfelli, mis on suunatud esmatasandi arstiabi ja pediaatrilistele turgudele. Ettevõtte peamised retseptiravimid ravivad tähelepanupuudulikkuse ja hüperaktiivsuse häiret (ADHD) ning teisi levinud lastehaigusi. Ettevõte turustab ADHD-ravimeid Adzenys XR-ODT (amfetamiin) toimeainet suukaudselt vabastavaid tablette, Cotempla XR-ODT (metüülfenidaat) toimeainet suukaudselt vabastavaid tablette ja Adzenys-ER (amfetamiin) toimeainet suukaudselt vabastavat suspensiooni. Ettevõtte teiste pediaatriliste toodete hulka kuuluvad Karbinal ER (karbinoksamiinmaleaat), karbinoksamiini (antihistamiin) toimeainet prolongeeritult vabastav suspensioon, mis on mõeldud paljude allergiliste seisundite raviks, ning Poly-Vi-Flor ja Tri-Vi-Flor, kaks täiendavat fluoriidipõhist retseptiravimite tootesarja, mis sisaldavad fluoriidi ja vitamiinide kombinatsioone fluoriidipuudusega imikutele ja lastele mõeldud preparaatides.

    Industry: Pharmaceuticals (NEC)

    373 Inverness Pkwy Ste 206
    80112

    Tuluaruanne

    • Annual
    • Quarterly

    Teised on vaadanud veel

    BTC/USD

    26,808.55 Price
    -0.840% 1D Chg, %
    Pika positsiooni ööpäeva tasu -0.0616%
    Lühikese positsiooni ööpäeva tasu 0.0137%
    Ööpäeva tasu aeg 21:00 (UTC)
    Hinnavahe 60.00

    Gold

    1,966.08 Price
    +0.060% 1D Chg, %
    Pika positsiooni ööpäeva tasu -0.0185%
    Lühikese positsiooni ööpäeva tasu 0.0103%
    Ööpäeva tasu aeg 21:00 (UTC)
    Hinnavahe 0.33

    US100

    14,587.90 Price
    +0.050% 1D Chg, %
    Pika positsiooni ööpäeva tasu -0.0255%
    Lühikese positsiooni ööpäeva tasu 0.0032%
    Ööpäeva tasu aeg 21:00 (UTC)
    Hinnavahe 1.8

    Oil - Crude

    72.80 Price
    +1.850% 1D Chg, %
    Pika positsiooni ööpäeva tasu -0.0179%
    Lühikese positsiooni ööpäeva tasu -0.0040%
    Ööpäeva tasu aeg 21:00 (UTC)
    Hinnavahe 0.04

    Kas otsite jätkuvalt vahendajat, keda saab usaldada?

    Ühinege 535,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com

    1. Looge ja kinnitage oma konto 2. Tee sissemakse 3. Alusta kauplemist